Planned acquisition of brelovitug for chronic hepatitis delta virus (HDV) with Breakthrough Therapy and PRIME ...

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, will ...

New "Financial First Aid for Nurses" Campaign Helps Nurses Treat Their Money Like They Treat Their Patients LAKE WORTH, ...

The new HER2DX central nervous system (CNS) progression score predicts risk of brain progression in advanced HER2+ breast cancer, addressing a major unmet need in identifying patients at the highest ...

Artificial Intelligence in Healthcare (2025)" report has been added to ResearchAndMarkets.com's offering.Artificial intelligence (AI) is transforming healthcare through automation, analytics, and ...

Operational real-world data analyzed from patients prescribed ZYNTEGLO™ and LYFGENIA™Data demonstrates the value proposition of one-time, durable gene therapy for the treatment of sickle cell disease ...

New analysis highlights a rising trend merging “technical jobs” and “people jobs” as roles increasingly demand a 50-50 balance of technical and human skillsSANTA MONICA, Calif.--(BUSINESS ...

Multiple long-term follow-up studies confirm BRUKINSA’s superior efficacy and favorable tolerability versus ibrutinib in relapsed or refractory CLLAdditional ASH data from investigational BTK degrader ...

Data presented at the 2025 American Epilepsy Society Annual MeetingPLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced the presentation of ...

Shipman sponsors premier event at new life sciences hub, celebrating innovative entrepreneurs.NEW HAVEN, Conn.--(BUSINESS WIRE)--BioCT, the CT life sciences trade organization, and Shipman & Goodwin ...

DUBLIN--(BUSINESS WIRE)--"Implementing CSA for GxP Systems - Transition, Documentation, and Post-Transition Challenges and Opportunities" training has been added to ResearchAndMarkets.com's ...

Orum Therapeutics (“Orum” or the “Company”) (KRX: 475830), a public biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today announced the presentation of preclinical ...